COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 2152: Articles 21511-21520  | Next

Photocatalyst under visible light irradiation inactivates SARS-CoV-2 on an abiotic surface
Uema, M., Yonemitsu, K., Momose, Y., Ishii, Y., Tateda, K., Inoue, T., Asakura, H.
10.1101/2020.11.01.364364 — Posted: 2020-11-02
Rapid inactivation of SARS-CoV-2 with ozone water
Inagaki, H., Saito, A., Sudaryatma, P. E., Sugiyama, H., Okabayashi, T., Fujimoto, S.
10.1101/2020.11.01.361766 — Posted: 2020-11-02
The effect of heat on SARS-CoV-2 viability and RNA integrity as determined by plaque assay, virus culture and real-time RT-PCR
Burton, J. E., Love, H., Richards, K., Burton, C., Summers, S., Pitman, J., Easterbrook, L., Davies, K., Spencer, P., Killip, M. J., Cane, P. A., Bruce, C. B., Roberts, A. D. G.
10.1101/2020.11.02.365015 — Posted: 2020-11-02
The SARS-CoV-2 RNA interactome
Lee, S., Lee, Y.-s., Choi, Y., Son, A., Park, Y., Lee, K.-M., Kim, J., Kim, J.-S., Kim, V. N.
10.1101/2020.11.02.364497 — Posted: 2020-11-02
Structural basis for repurpose and design of nucleoside drugs for treating COVID-19
Yin, W., Luan, X., Li, Z., Xie, Y., Zhou, Z., Liu, J., Gao, M., Wang, X., Zhou, F., Wang, Q., Wang, Q., Shen, D., Zhang, Y., Tian, G., Aisa, H. A., Hu, T., Wei, D., Jiang, Y., Xiao, G., Jiang, H., Zhang, L., Yu, X., Shen, J., Zhang, S., Xu, H. E.
10.1101/2020.11.01.363812 — Posted: 2020-11-02
Predicting the animal hosts of coronaviruses from compositional biases of spike protein and whole genome sequences through machine learning
Brierley, L., Fowler, A.
10.1101/2020.11.02.350439 — Posted: 2020-11-02
Discovery of five HIV nucleoside analog reverse-transcriptase inhibitors (NRTIs) as potent inhibitors against the RNA-dependent RNA polymerase (RdRp) of SARS-CoV and 2019-nCoV
Sun, J.
10.1101/2020.11.01.363788 — Posted: 2020-11-01
Viral genome sequencing places White House COVID-19 outbreak into phylogenetic context
Bedford, T., Logue, J. K., Han, P. D., Wolf, C. R., Frazar, C. D., Pelle, B., Ryke, E., Lee, J., Rieder, M. J., Nickerson, D. A., Lockwood, C. M., Starita, L. M., Chu, H. Y., Shendure, J.
10.1101/2020.10.31.20223925 — Posted: 2020-11-01 Discussion: Onsite
A model for pH coupling of the SARS-CoV-2 spike protein open/closed equilibrium.
Warwicker, J.
10.1101/2020.10.31.363176 — Posted: 2020-11-01
Tetravalent SARS-CoV-2 Neutralizing Antibodies Show Enhanced Potency and Resistance to Escape Mutations
Miersch, S., Li, Z., Saberianfar, R., Ustav, M., Blazer, L., Chen, C., Ye, W., Pavlenco, A., Subramnia, S., Singh, S., Ploder, L., Ganaie, S., Leung, D., Case, J. B., Novelli, G., Matusali, G., Chen, R., Colavita, F., Copabianchi, M. R., Jain, S., Gupta, J. B., Amarasinghe, G., Diamond, M. S., Rini, J., Sidhu, S.
10.1101/2020.10.31.362848 — Posted: 2020-11-01 Discussion: Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).